Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.510, 2006-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Highest-risk patients miss out on much-needed HF therapy
Inpharma, Vol. 1, Iss. 1506, 2005-01 ,pp. :
Sygnis receives orphan drug designation for AX 200.
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :
Sapacitabine receives orphan drug designation in EU.
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
STX 100 receives orphan drug designation in the US.
Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. :